⌘K

Login Start Free

Lexaria Bioscience Corp.·4

Jul 30, 5:12 PM ET

BUNKA CHRISTOPHER 4

4 · Lexaria Bioscience Corp. · Filed Jul 30, 2025

Insider Transaction Report

Form 4

Period: 2025-07-29

Lexaria Bioscience Corp.LEXX

BUNKA CHRISTOPHER

DirectorChariman/CEO/President/CFO

Transactions

Purchase
common shares
2025-07-30$0.91/sh+11,900$10,866→ 281,912 total(indirect: Private Holding Company)
Purchase
common shares
2025-07-29$0.92/sh+15,600$14,375→ 270,012 total(indirect: Private Holding Company)

Holdings

Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying)
26,000
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
94,334
common shares
(indirect: Private Holding Company)
254,412
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying)
173,834
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)
64,334
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying)
124,334
Stock Options
Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (11,000 underlying)
184,834
common shares
373,543
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (23,334 underlying)
49,334

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT